Yigal M. Pinto

29.5k citations

218 papers · 15.9k indexed · 5 hit papers · h-index 67

Cardiology and Cardiovascular Medicine top 0.1%
- Heart Failure Treatment and Management 53
- Cardiomyopathy and Myosin Studies 43
- Cardiovascular Effects of Exercise 31
- Cardiovascular Function and Risk Factors 31
- Renin-Angiotensin System Studies 29
- Cardiac Fibrosis and Remodeling 19
Cancer Research top 0.2%
- MicroRNA in disease regulation 20
Molecular Biology top 0.5%
- RNA Research and Splicing 31
Immunology top 2%
Nephrology top 2%

Co-authors: Esther E. Creemers Anke J. Tijsen Harry J.G.M. Crijns James L. Januzzi Antoni Bayés‐Genís Blanche Schroen León J. De Windt Mark Richards
Cited by: Cardiology and Cardiovascular Medicine Cancer Research Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)Journal of Biological Chemistry (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Yigal M. Pinto

213 papers receiving 15.6k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2012 Circulation Research
2010 Circulation Research
2008 Circulation Research
2005 European Heart Journal
2004 Circulation

Peers

Countries citing papers authored by Yigal M. Pinto

Since Specialization

Citations

This map shows the geographic impact of Yigal M. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yigal M. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yigal M. Pinto more than expected).

Fields of papers citing papers by Yigal M. Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yigal M. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yigal M. Pinto. The network helps show where Yigal M. Pinto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yigal M. Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yigal M. Pinto Line = papers co-authored together Yigal M. Pinto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Polygenic Risk Scores in Dilated Cardiomyopathy: Towards the Future Current Cardiology Reports ·Daria R. Kramarenko,Sean J. Jurgens,Yigal M. Pinto,Connie R. Bezzina,Ahmad S. Amin	2025	1
2	Cardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes Circulation Cardiovascular Imaging ·Sjoerd M Verwijs,J C Van Hattum,J J N Daems,S. Matthijs Boekholdt,R. Nils Planken,Maarten Groenink,Adriënne van Randen,Raschel D van Luijk,Jules L. Nelissen,Maarten H. Moen,Birgitta K. Velthuis,Yigal M. Pinto,ARTHUR A. M. WILDE,Niek H. J. Prakken,H T Jørstad	2025	0
3	Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports Heart ·J C Van Hattum,Joëlle J N Daems,Sjoerd M Verwijs,Leonoor V. Wismans,M A Van Diepen,Maarten Groenink,S. Matthijs Boekholdt,R. Nils Planken,Adriënne van Randen,Alexander Hirsch,Maarten H. Moen,Yigal M. Pinto,Arthur A.M. Wilde,H T Jørstad	2023	1
4	Quaking regulates circular RNA production in cardiomyocytes Journal of Cell Science ·Pablo Montañés-Agudo,Ingeborg van der Made,Simona Aufiero,Anke J. Tijsen,Yigal M. Pinto,Esther E. Creemers	2023	14
5	The RNA-binding protein QKI governs a muscle-specific alternative splicing program that shapes the contractile function of cardiomyocytes Cardiovascular Research ·Pablo Montañés-Agudo,Simona Aufiero,Eva N Schepers,Ingeborg van der Made,Lucía Cócera-Ortega,Auriane C. Ernault,Stéphane Richard,Diederik W.D. Kuster,Vincent M. Christoffels,Yigal M. Pinto,Esther E. Creemers	2023	28
6	Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients Journal of Cardiovascular Translational Research ·Joseph Debbs,Bashar Hannawi,Edward L. Peterson,Hongsheng Gui,Nicole Zeld,Jasmine A. Luzum,Hani N. Sabbah,James Snider,Yigal M. Pinto,L. Keoki Williams,David E. Lanfear	2023	1
7	shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele International Journal of Molecular Sciences ·Lucía Cócera-Ortega,Ronald Wilders,Selina C. Kamps,Benedetta Fabrizi,Irit Huber,Ingeborg van der Made,Anouk van den Bout,Dylan K. de Vries,Lior Gepstein,Arie O. Verkerk,Yigal M. Pinto,Anke J. Tijsen	2022	5
8	Case report: the role of multimodal imaging to optimize the timing of return to sports in an elite athlete with persistent COVID-19 myocardial inflammation European Heart Journal - Case Reports ·Joëlle J N Daems,J C Van Hattum,Yigal M. Pinto,H T Jørstad	2022	4
9	Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction Circulation Genomic and Precision Medicine ·Hongsheng Gui,Ruicong She,Jasmine A. Luzum,Jia Li,Timothy D. Bryson,Yigal M. Pinto,Hani N. Sabbah,L. Keoki Williams,David E. Lanfear	2021	16
10	The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin–angiotensin system European Heart Journal - Cardiovascular Pharmacotherapy ·Annette K. Offringa,R.C. Montijn,Sandeep Singh,Martin Paul,Yigal M. Pinto,Sara‐Joan Pinto‐Sietsma	2020	39
11	NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure Circulation ·Susan Stienen,Khibar Salah,Arno H. Moons,Adrianus L. M. Bakx,Petra van Pol,R. A. Mikael Kortz,João Pedro Ferreira,Irene Marques,Jutta M. Schroeder‐Tanka,J. Keijer,Antoni Bayés‐Genís,Jan G.P. Tijssen,Yigal M. Pinto,Wouter E.M. Kok	2017	101
12	Prognostic Value of Circulating microRNAs on Heart Failure-Related Morbidity and Mortality in Two Large Diverse Cohorts of General Heart Failure Patients European Journal of Heart Failure ·Antoni Bayés‐Genís,David E. Lanfear,Maurice W.J. de Ronde,Josep Lupón,Joost J. Leenders,Zhen Liu,Nicolaas P. A. Zuithoff,Marinus J.C. Eijkemans,Elisabet Zamora,Marta de Antonio,Aeilko H. Zwinderman,Sara‐Joan Pinto‐Sietsma,Yigal M. Pinto	2017	66
13	Truncating Titin Mutations are Associated with a Mild and Treatable form of Dilated Cardiomyopathy European Journal of Heart Failure ·Joeri A. Jansweijer,Karin Nieuwhof,Francesco Paolo Russo,Edgar T. Hoorntje,Jan D.H. Jongbloed,Ronald H. Lekanne Deprez,Alex V. Postma,Marieke Bronk,Ingrid A.W. van Rijsingen,Simone de Haij,Elena Biagini,Paul L. van Haelst,Jan van Wijngaarden,Maarten P. van den Berg,Arthur A.M. Wilde,Marcel M. A. M. Mannens,Rudolf A. de Boer,Karin Y. van Spaendonck‐Zwarts,J. Peter van Tintelen,Yigal M. Pinto	2016	108
14	Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials European Journal of Heart Failure ·Hans‐Peter Brunner‐La Rocca,Luc W.M. Eurlings,Mark Richards,James L. Januzzi,Matthias Pfisterer,Ulf Dahlström,Yigal M. Pinto,Patric Karlström,Hans Erntell,Rudolf Berger,Hans Persson,Christopher M. O’Connor,Deddo Moertl,Hanna K. Gaggin,Christopher Frampton,M. Gary Nicholls,Richard W. Troughton	2015	67
15	Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels? European Journal of Heart Failure ·Susan Stienen,Khibar Salah,Luc W.M. Eurlings,Paulo Bettencourt,Joana Pimenta,Marco Metra,Antoni Bayés‐Genís,Valerio Verdiani,Luca Bettari,Valentina Lazzarini,Jan Tijssen,Yigal M. Pinto,Wouter E.M. Kok	2015	26
16	A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score Heart ·Khibar Salah,Wouter E.M. Kok,Luc W.M. Eurlings,Paulo Bettencourt,Joana Pimenta,Marco Metra,Antoni Bayés‐Genís,Valerio Verdiani,Luca Bettari,Valentina Lazzarini,Peter Damman,Jan G.P. Tijssen,Yigal M. Pinto	2013	95
17	Genetic Analysis in 418 Index Patients with Idiopathic Dilated Cardiomyopathy: Overview of 10 Years’ Experience European Journal of Heart Failure ·Karin Y. van Spaendonck‐Zwarts,Ingrid A.W. van Rijsingen,Maarten P. van den Berg,Ronald H. Lekanne Deprez,Jan G. Post,Anneke M. van Mil,Folkert W. Asselbergs,Imke Christiaans,Irene M. van Langen,Arthur A.M. Wilde,Rudolf A. de Boer,Jan D.H. Jongbloed,Yigal M. Pinto,J. Peter van Tintelen	2013	114
18	Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner European Heart Journal ·Ahmad S. Amin,John R. Giudicessi,Anke J. Tijsen,Anne M. Spanjaart,Yolan J. Reckman,Christine A. Klemens,Michael W.T. Tanck,Jamie D. Kapplinger,Nynke Hofman,Moritz F. Sinner,Martina Müller‐Nurasyid,Wino J. Wijnen,Hanno L. Tan,Connie R. Bezzina,Esther E. Creemers,Arthur A.M. Wilde,Michael J. Ackerman,Yigal M. Pinto	2011	94
19	Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction The Journal of Experimental Medicine ·Mark W.M. Schellings,Davy Vanhoutte,Melissa Swinnen,Jack P.M. Cleutjens,Jacques Debets,Rick E.W. van Leeuwen,Jan D’hooge,Frans Van de Werf,Peter Carmeliet,Yigal M. Pinto,E. Helene Sage,Stéphane Heymans	2008	166
20	A-type lamins are essential for TGF-β1 induced PP2A to dephosphorylate transcription factors Human Molecular Genetics ·Jop H. van Berlo,Jan Willem Voncken,Nard Kubben,Jos L. V. Broers,Rudy F. Duisters,Rick E.W. van Leeuwen,Harry J.G.M. Crijns,Frans C. S. Ramaekers,Christopher J. Hutchison,Yigal M. Pinto	2005	129

About Yigal M. Pinto

Yigal M. Pinto is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology, having authored 218 papers that have together received 15.9k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (53 papers), Cardiomyopathy and Myosin Studies (43 papers), Cardiovascular Effects of Exercise (31 papers), Cardiovascular Function and Risk Factors (31 papers), RNA Research and Splicing (31 papers), Renin-Angiotensin System Studies (29 papers), MicroRNA in disease regulation (20 papers) and Cardiac Fibrosis and Remodeling (19 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.9k citations), Cancer Research (3.2k citations) and Molecular Biology (7.2k citations). Yigal M. Pinto has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Esther E. Creemers, Anke J. Tijsen, Harry J.G.M. Crijns, James L. Januzzi, Antoni Bayés‐Genís, Blanche Schroen, León J. De Windt, Mark Richards, Umesh C. Sharma and Stéphane Heymans. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact